Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening

摘要

(Abstracted from Obstet Gynecol 2022;140:121–131) Early detection and targeted treatment of human disorders are the goal of precision medicine. The advancing technology of cell-free DNA (cfDNA) is increasingly being applied in screening, diagnosis, and treatment of several disease processes.